Overview of Zopiclone Biogaran
| Property | Description |
|---|---|
| Active ingredient | Zopiclone (INN) |
| Form | Film-coated tablet |
| Pharmacological class | Non-benzodiazepine hypnotic (Cyclopyrrolone) |
| Common use | Addressing short-term difficulties with sleep |
| Origin | Synthetic |
What Type of Medicine is Zopiclone Biogaran?
Zopiclone Biogaran is a prescription-only hypnotic agent classified pharmacologically as a cyclopyrrolone. This medication belongs to the family of non-benzodiazepine hypnotics, widely known as Z-drugs, which are specifically designed to address difficulties related to sleep. Under the Anatomical Therapeutic Chemical (ATC) system, this substance is categorized with the code N05CF01 as a benzodiazepine-related drug. The medication is characterized by its ability to promote rest rapidly.
The drug's designation as a Z-drug distinguishes its structure from traditional benzodiazepine sedatives, although it shares the ultimate purpose of promoting rest. Zopiclone Biogaran is a brand marketed primarily in European regions, where it is established as a generic formulation of the active compound zopiclone.
Composition, Form, and Chemical Origin
The active substance in this preparation is zopiclone, a chemically synthetic compound that is presented for the oral route of administration as a film-coated tablet. Zopiclone is a single-ingredient product, containing only the INN compound as the sole therapeutically active agent.
Zopiclone is a racemic mixture (±-zopiclone) of two stereoisomers. The tablets are engineered with solid excipients to ensure standardized delivery of the zopiclone compound. This class of agents is indicated for the management of short-term insomnia based on their general hypnotic effect. The consistent form of the film-coated tablet ensures the delivery of the synthetic compound.
The Function of Zopiclone as a Sleep Aid (General Purpose)
The overall function of zopiclone is to promote rest by facilitating the brain's natural calming processes. It achieves this by selectively enhancing the effects of the inhibitory neurotransmitter Gamma-aminobutyric acid (GABA). This selective action on the GABAergic system allows the medication to support the body in overcoming the neural hyper-arousal often associated with insomnia. The general purpose of the drug is to aid individuals who experience typical symptoms of short-term sleep disturbance, such as having difficulty falling asleep or waking frequently during the night, by supporting the transition to a sustained, restful state.

